Netherlands· NL-35da66b5512b
Sandomigran 0,5 mg, omhulde tabletten 0,5 mg
A pizotifen product containing pizotifeen waterstofmalaat, registered in Netherlands by Phoenix Labs. The same ATC class is registered in 7 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Pizotifen is registered in 7 of 19 countries.
Countries holding a registration under ATC N02CX01 (pizotifen), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 3 of them publish a price we can compare per daily dose
Pizotifen · ATC N02CX01
7 / 19 countries
- Belgiumprice
- Canada
- Finlandprice
- Ireland
- Netherlands
- Norwayprice
- United Kingdom
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- PIZOTIFEEN WATERSTOFMALAAT
- Manufacturer
- Phoenix Labs
- Country
- Netherlands (NL)
- ATC code
- N02CX01
- ATC class
- Pizotifen
- Defined daily dose
- 1.5 mg, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id06258
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Pizotifen in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumSandomigran 0,5 mgNovartis Pharma
- FranceSANMIGRAN 0,50 mg, comprimé enrobéPHOENIX LABS (IRLANDE)
- IrelandSanomigran 500 microgram TabletsPhoenix Labs
- United KingdomPizotifen 1.5mg tabletsDE Pharmaceuticals
- SpainMOSEGOR 0,5 mg/10 ml SOLUCION ORALEthyx Pharmaceuticals
- NorwaySandomigrinEthyx Pharmaceuticals SAS
- CanadaSANDOMIGRAN DSENDO OPERATIONS LTD.
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- Cyprus · Pizogran
- Spain · Mosegor
- United Kingdom (Northern Ireland) · Pizotifen Tillomed Laboratories
- Ireland · Sanomigran
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/42c34b72-dab7-4446-9ee1-801ef4fe5b60 GET /v1/drugs/42c34b72-dab7-4446-9ee1-801ef4fe5b60?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Omhulde tablet",
"route": "Oraal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h06258_smpc.pdf",
"strength": null,
"atc_label": "Pizotifen",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg06258",
"excipients": [
"ARABISCHE GOM (E 414)",
"CETYLPALMITAAT",
"ISOPROPYLALCOHOL",
"LACTOSE 1-WATER",
"MAGNESIUMSTEARAAT (E 470b)",
"MAÏSZETMEEL",
"POVIDON (E 1201)",
"SACCHAROSE",
"SILICIUMDIOXIDE (E 551)",
"TALK (E 553b)",
"TITAANDIOXIDE (E 171)"
],
"substances": [
"PIZOTIFEEN WATERSTOFMALAAT"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h06258.pdf",
"authorised_at": "1971/06/23",
"procedure_number": null,
"dispensing_status": "Uitsluitend recept",
"registration_number": "06258",
"additional_monitoring": "N"
}See everything about pizotifen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.